Tim G. Call

1.8k total citations · 1 hit paper
12 papers, 1.2k citations indexed

About

Tim G. Call is a scholar working on Genetics, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Tim G. Call has authored 12 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 7 papers in Pathology and Forensic Medicine and 3 papers in Immunology. Recurrent topics in Tim G. Call's work include Chronic Lymphocytic Leukemia Research (11 papers), Lymphoma Diagnosis and Treatment (7 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). Tim G. Call is often cited by papers focused on Chronic Lymphocytic Leukemia Research (11 papers), Lymphoma Diagnosis and Treatment (7 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). Tim G. Call collaborates with scholars based in United States, Spain and Germany. Tim G. Call's co-authors include Tait D. Shanafelt, Neil E. Kay, Colin P. West, Jeff A. Sloan, John H. Davidson, Liselotte N. Dyrbye, Susan A. Romanski, Clive S. Zent, Diane F. Jelinek and Betsy LaPlant and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Haematology.

In The Last Decade

Tim G. Call

12 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Intervention to Promote Physician Well-being, Job Satisfaction, and Professionalism

2014 455 citations Colin P. West, Liselotte N. Dyrbye et al. JAMA Internal Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tim G. Call United States	10	496	427	383	261	244	12	1.2k
Lorri Puil Canada	16	243 0.5×	514 1.2×	88 0.2×	110 0.4×	293 1.2×	33	1.7k
Sarah E. Daugherty United States	19	81 0.2×	72 0.2×	199 0.5×	66 0.3×	143 0.6×	33	1.4k
Julie Dubois Switzerland	12	180 0.4×	95 0.2×	47 0.1×	79 0.3×	49 0.2×	54	510
Р. С. Карпов Russia	14	37 0.1×	179 0.4×	105 0.3×	80 0.3×	59 0.2×	173	1.2k
Jo Wick United States	16	37 0.1×	52 0.1×	103 0.3×	38 0.1×	280 1.1×	67	1.0k
Giovanni Zanconato Italy	28	25 0.1×	30 0.1×	119 0.3×	145 0.6×	394 1.6×	65	2.4k
Dean H. Gesme United States	16	193 0.4×	84 0.2×	126 0.3×	11 0.0×	224 0.9×	33	1.4k
Carolyn Harley United States	14	44 0.1×	38 0.1×	92 0.2×	28 0.1×	146 0.6×	33	980
Hao Tang China	21	23 0.0×	60 0.1×	100 0.3×	43 0.2×	152 0.6×	72	1.2k
I. Gilloteau United States	18	59 0.1×	101 0.2×	59 0.2×	504 1.9×	123 0.5×	48	998

Countries citing papers authored by Tim G. Call

Since Specialization

Citations

This map shows the geographic impact of Tim G. Call's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim G. Call with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim G. Call more than expected).

Fields of papers citing papers by Tim G. Call

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim G. Call. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim G. Call. The network helps show where Tim G. Call may publish in the future.

Co-authorship network of co-authors of Tim G. Call

This figure shows the co-authorship network connecting the top 25 collaborators of Tim G. Call. A scholar is included among the top collaborators of Tim G. Call based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tim G. Call. Tim G. Call is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Sinha, Sutapa, Justin C. Boysen, Kari G. Chaffee, et al.. (2018). Chronic lymphocytic leukemia cells from ibrutinib treated patients are sensitive to Axl receptor tyrosine kinase inhibitor therapy. Oncotarget. 9(98). 37173–37184. 9 indexed citations

Larsen, Jeremy T., Tait D. Shanafelt, José F. Leis, et al.. (2017). Akt inhibitor MK‐2206 in combination with bendamustine and rituximab in relapsed or refractory chronic lymphocytic leukemia: Results from the N1087 alliance study. American Journal of Hematology. 92(8). 759–763. 18 indexed citations

Strati, Paolo, Samih H. Nasr, Nelson Leung, et al.. (2015). Renal complications in chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis: the Mayo Clinic experience. Haematologica. 100(9). 1180–1188. 58 indexed citations

Shanafelt, Tait D., Bijan J. Borah, Heidi D. Finnes, et al.. (2015). Impact of Ibrutinib and Idelalisib on the Pharmaceutical Cost of Treating Chronic Lymphocytic Leukemia at the Individual and Societal Levels. Journal of Oncology Practice. 11(3). 252–258. 79 indexed citations

Slager, Susan L., Yolanda Benavente, A. Blair, et al.. (2014). Medical History, Lifestyle, Family History, and Occupational Risk Factors for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: The InterLymph Non-Hodgkin Lymphoma Subtypes Project. JNCI Monographs. 2014(48). 41–51. 70 indexed citations

West, Colin P., Liselotte N. Dyrbye, Tim G. Call, et al.. (2014). Intervention to Promote Physician Well-being, Job Satisfaction, and Professionalism. JAMA Internal Medicine. 174(4). 527–527. 455 indexed citations breakdown →

Shanafelt, Tait D., John C. Byrd, Betsy LaPlant, et al.. (2009). Pretreatment angiogenic cytokines predict response to chemoimmunotherapy in patients with chronic lymphocytic leukaemia. British Journal of Haematology. 146(6). 660–664. 10 indexed citations

Shanafelt, Tait D., Tim G. Call, Clive S. Zent, et al.. (2009). Phase I Trial of Daily Oral Polyphenon E in Patients With Asymptomatic Rai Stage 0 to II Chronic Lymphocytic Leukemia. Journal of Clinical Oncology. 27(23). 3808–3814. 142 indexed citations

Shanafelt, Tait D., Neil E. Kay, Tim G. Call, et al.. (2008). MBL or CLL: Which classification best categorizes the clinical course of patients with an absolute lymphocyte count ≥5×109L−1 but a B-cell lymphocyte count <5×109L−1?. Leukemia Research. 32(9). 1458–1461. 31 indexed citations

10.

Shanafelt, Tait D., Susan M. Geyer, Nancy D. Bone, et al.. (2008). CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential. British Journal of Haematology. 140(5). 537–546. 118 indexed citations

11.

Shanafelt, Tait D., Thomas E. Witzig, Stephanie Fink, et al.. (2006). Prospective Evaluation of Clonal Evolution During Long-Term Follow-Up of Patients With Untreated Early-Stage Chronic Lymphocytic Leukemia. Journal of Clinical Oncology. 24(28). 4634–4641. 184 indexed citations

12.

Shanafelt, Tait D., Susan M. Geyer, Susan M. Schwager, et al.. (2005). Evaluation of the Prognostic Implications of Pro- and Anti-Angiogenic Cytokines in 311 Patients with Untreated Chronic Lymphocytic Leukemia.. Blood. 106(11). 712–712. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact